SRSD216

· Sirius Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SRSD216, covering 2026-01-06 to 2026-01-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SRSD216 in Patients With Elevated Lipoprotein (a) [Phase 1, Phase 2]